Recipient Title Vice President and General Manager, kdc/one Chatsworth, Inc., 20320 Prairie St. Chatsworth , CA 91311-6026 United StatesFEI 1000519695Issued Sep 8, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 1000519695.
Violations4
Issue DateSep 8, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
kdc/one Chatsworth, Inc.
Location
Recipient Title Vice President and General Manager, kdc/one Chatsworth, Inc., 20320 Prairie St. Chatsworth , CA 91311-6026 United States
FEI Number
1000519695
Country
United States
Issue Date
September 08, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
kdc/one Chatsworth, Inc. FDA Warning Letter, September 8, 2026
Talk to a Specialist